908 Devices (MASS) Total Debt (2020 - 2026)

908 Devices (MASS) posted quarterly Total Debt of $22.4 million for Q1 2026, up 39.82% quarter-over-quarter from $16.0 million in Q4 2025.

908 Devices (MASS) Total Debt (2020 - 2026) Analysis & Trends

908 Devices (MASS) has reported Total Debt for 6 consecutive years, with $22.4 million the latest figure, recorded in Q1 2026.

In Q1 2026, Total Debt changed N/A year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $22.4 million (changed N/A YoY), while the FY2025 annual figure was $16.0 million, changed N/A from the prior year.
Total Debt grew to $22.4 million in Q1 2026 per MASS's latest filing, from $16.0 million in the prior quarter.
Across five years, Total Debt topped out at $23.0 million in Q3 2025 and bottomed at $500000.0 in Q4 2023.
Historically, Total Debt has averaged $11.5 million across 4 years, with a median of $15.0 million in 2022.
Annual changes were most pronounced in 2022 — Total Debt gained 8.29% — and 2023, when it sank 96.92%.
908 Devices' Total Debt stood at $16.2 million in 2022, then tumbled by 96.92% to $500000.0 in 2023, then surged by 3105.0% to $16.0 million in 2025, then soared by 39.82% to $22.4 million in 2026.
Business Quant data shows MASS's Total Debt at $22.4 million in Q1 2026, $16.0 million in Q4 2025, and $23.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn	32.61 Bn
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn	14.94 Bn
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn	27.96 Bn
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn	12.62 Bn
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	10.10 Bn
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	8.68 Bn
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn	1.89 Bn
10	908 Devices	386.52 Mn	284.99 Mn	8.34 Mn	27.96 Mn

Download Data